Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA sends more than 100 warning letters to firms over new synthetic nicotine law

The FDA has vowed to take more action in the coming weeks.

Axios

Gateshead's Shield Therapeutics awaits Canadian regulatory approval for iron deficiency drug

The pharmaceutical firm says Health Canada will screen its Accrufer lead product, with an outcome expected next year

Birmingham Post

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA authorizes protein-based Novavax Covid vaccine for adults

Approval of shot widens options against the virus as CDC will meet next week to decide whether to sign off on vaccine

The Guardian - US

Novavax Tanks On New Troubles For Its Newly Authorized Covid Vaccine

The FDA authorized Novavax's Covid vaccine for emergency use, but NVAX stock tumbled on Thursday on warnings facing the two-dose regimen.

Investors Business Daily

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice

The Independent UK

Novavax Covid vaccine becomes fourth to receive FDA approval

The protein-based vaccine still needs to be approved by the CDC before it can start to be administered

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

FDA authorizes Novavax COVID vaccine for emergency use

"Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19."

Axios

PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment

Ketamine pharmaceuticals provider PharmaTher Holdings Ltd. (OTCQB: PHRRF) has been granted a Notice of Allowance by the U.S.

Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Benzinga

Science Wednesday: Where To See Comet K2 As It Passes The Earth

Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across the universe, with a nucleus believed to be around 11 miles in diameter and a…

Benzinga

Poll: Only 26 Percent of Democrats Want Biden To Run in 2024

Plus: Psilocybin microdosing improves mood, vaping regulations backfire, and more...

Reason

Inhale Success: Blakk Tatted Becomes Overnight Millionaire With Hookah Brand

NEW ORLEANS — Blakk Tatted loves the idea of being an overnight success.

Zenger

Will Americans have the right COVID-19 vaccine this fall? Maybe

In a few short months, the weather will turn crisp, the holiday season will draw near, and the coronavirus may embark on its third consecutive winter of death and devastation.

Los Angeles Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

The Philadelphia Inquirer

Why BA.5 is not a super-virus, and how the vaccines are still the best option against COVID

The BA.5 “subvariant” of the coronavirus has rapidly become dominant in the United States, and rising COVID-19 case numbers are dashing hopes for a summer break from the pandemic.

Reason

The U.S. Government Had What It Needed To Prevent the Spread of Monkeypox. It Happened Anyway.

Foot-dragging and red tape by the CDC and the FDA have fueled an avoidable outbreak.

Benzinga

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

Image sourced from Shutterstock

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Chicago Sun-Times

The scoop on microwaves: myth versus fact about this kitchen staple

Contrary to the belief that microwaves cook from the inside out, they actually heat the outer layers, which transfer heat to the inner portions.

The Independent UK

Pig organ transplants inch closer with testing in the dead

Researchers at New York University transplanted pig hearts into two brain-dead people over the last month, the latest in a string of developments in the long quest to one day save human lives with animal organs

Reason

States Must Allow Abortions When Woman's Health or Life Is Threatened, Says HHS

Plus: When "anti-wokeness" becomes an obsession, why immigrants are upwardly mobile, and more...

Benzinga

Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug

Akanda Corp.

Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner

Here's a roundup of top developments in the biotech space over the last 24 hours:

StockNews.com

Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

1 … 125 126 127 128

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.